Savient Pharmaceuticals, Inc. Reports Second Quarter 2013 Financial Results
Regeneron may be hiring! Check it out! (Isn't it tempting?)
BRIDGEWATER, N.J., Aug. 14, 2013 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (SVNT) today reported financial results for the three and six-month periods ended June 30, 2013. Net sales for KRYSTEXXA® were $6.1 million for the second quarter of 2013, a 38% increase over the first quarter of 2013.
Help employers find you! Check out all the jobs and post your resume.
BRIDGEWATER, N.J., Aug. 14, 2013 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (SVNT) today reported financial results for the three and six-month periods ended June 30, 2013. Net sales for KRYSTEXXA® were $6.1 million for the second quarter of 2013, a 38% increase over the first quarter of 2013.
Help employers find you! Check out all the jobs and post your resume.